Neumora Therapeutics Inc. (NASDAQ: NMRA): Stock Forecast For 2024 Still Looks Weak With A -96.74% Decline
In the last trading session, 1.33 million shares of the Neumora Therapeutics Inc. (NASDAQ:NMRA) were traded, and its beta was 3.38. Most recently the company’s